Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain (RER)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01946555
Recruitment Status : Completed
First Posted : September 19, 2013
Last Update Posted : April 14, 2016
Sponsor:
Information provided by (Responsible Party):
Mario Negri Institute for Pharmacological Research